http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007128055-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10821badccf8bfe8ef991ff8f2f6c7c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_db5d0d3ef29663d5461031d94cae772b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7de920fe5473c0750716879bf435d91a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c037e4d16a38eca958647aa0ed081e4e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a569ca7c15b5fd3da8db23affefb050
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2240-002
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-1624
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-50
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-013
filingDate 2007-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_213bdba40f1a861f5dad2c2bcf5d629a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a5795f503c47a2fcddba0fe378fd5a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db3f650aa90ba9197919d8b3c06d80f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e6b5bf4acb35dfd3fdfd563cd16c1f5
publicationDate 2007-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007128055-A1
titleOfInvention Eye treatment
abstract The present invention relates to a method of determining the IOL refractive index for an ocular replacement material for replacing tissue in the capsular bag comprising combining a neutral (non-correcting) reference refractive index ('NRRI') of between 1.421 and 1.450 with a refractive index correction factor ('RICF') ascertained by reference to the refractive power required to correct the patient's refractive error. The present invention also relates to methods of treating presbyopia, myopia and hyperopia using the above method.
priorityDate 2006-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004011529-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006135477-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6589550-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4542542-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0189435-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6361561-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6747090-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393292
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408759
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8400
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164054248
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408757
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID174174
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12562731
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408758
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11105370
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395164
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226500998
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7274
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5910
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3661
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395163
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465870736
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405615
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411174
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2905

Total number of triples: 49.